DrugCite
Search

BETASERC

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Betaserc Adverse Events Reported to the FDA Over Time

How are Betaserc adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Betaserc, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Betaserc is flagged as the suspect drug causing the adverse event.

Most Common Betaserc Adverse Events Reported to the FDA

What are the most common Betaserc adverse events reported to the FDA?

Pruritus
7 (4%)
Bradycardia
5 (2.86%)
Drug Rash With Eosinophilia And Sys...
5 (2.86%)
Hyperlactacidaemia
5 (2.86%)
Malaise
5 (2.86%)
Orthostatic Hypotension
5 (2.86%)
Gastroenteritis
4 (2.29%)
Loss Of Consciousness
4 (2.29%)
Rash Papular
4 (2.29%)
Renal Failure Acute
4 (2.29%)
Toxic Skin Eruption
4 (2.29%)
Show More Show More
Blood Alkaline Phosphatase Increase...
3 (1.71%)
Cholestatic Liver Injury
3 (1.71%)
Drug Eruption
3 (1.71%)
Gamma-glutamyltransferase Increased
3 (1.71%)
Hepatitis
3 (1.71%)
Hyponatraemia
3 (1.71%)
Renal Failure
3 (1.71%)
Weight Decreased
3 (1.71%)
Blood Creatinine Increased
2 (1.14%)
Cerebral Haemorrhage
2 (1.14%)
Confusional State
2 (1.14%)
Creatinine Renal Clearance Decrease...
2 (1.14%)
Dehydration
2 (1.14%)
Eosinophilia
2 (1.14%)
Jaundice
2 (1.14%)
Leukocytosis
2 (1.14%)
Lymphadenopathy
2 (1.14%)
Nausea
2 (1.14%)
Overdose
2 (1.14%)
Pancytopenia
2 (1.14%)
Protein Total Increased
2 (1.14%)
Pyrexia
2 (1.14%)
Rash
2 (1.14%)
Rash Erythematous
2 (1.14%)
Sepsis
2 (1.14%)
Thrombocytopenia
2 (1.14%)
Vomiting
2 (1.14%)
White Blood Cell Count Increased
2 (1.14%)
Abdominal Discomfort
1 (.57%)
Abdominal Pain
1 (.57%)
Activities Of Daily Living Impaired
1 (.57%)
Asthenia
1 (.57%)
Autonomic Nervous System Imbalance
1 (.57%)
Balance Disorder
1 (.57%)
Biopsy Skin Abnormal
1 (.57%)
Blood Bilirubin Increased
1 (.57%)
Blood Calcium Increased
1 (.57%)
Cervicobrachial Syndrome
1 (.57%)
Chills
1 (.57%)
Cholestasis
1 (.57%)
Chromaturia
1 (.57%)
Conjunctival Pallor
1 (.57%)
Constipation
1 (.57%)
Convulsion
1 (.57%)
Cupulolithiasis
1 (.57%)
Decreased Appetite
1 (.57%)
Depression
1 (.57%)
Diarrhoea
1 (.57%)
Dizziness
1 (.57%)
Dysstasia
1 (.57%)
Erysipelas
1 (.57%)
Faeces Discoloured
1 (.57%)
Fear
1 (.57%)
Fear Of Falling
1 (.57%)
Feeling Abnormal
1 (.57%)
Fixed Eruption
1 (.57%)
Gait Disturbance
1 (.57%)
General Physical Health Deteriorati...
1 (.57%)
Headache
1 (.57%)
Hepatitis Acute
1 (.57%)
Hepatitis Cholestatic
1 (.57%)
Hepatocellular Injury
1 (.57%)
Hypotension
1 (.57%)
Melaena
1 (.57%)
Myelofibrosis
1 (.57%)
Nervous System Disorder
1 (.57%)
Nystagmus
1 (.57%)
Oedema Peripheral
1 (.57%)
Oesophagitis
1 (.57%)
Pallor
1 (.57%)
Panic Disorder
1 (.57%)
Pruritus Generalised
1 (.57%)
Rash Macular
1 (.57%)
Rash Pruritic
1 (.57%)
Rash Pustular
1 (.57%)
Skin Hyperpigmentation
1 (.57%)
Skin Necrosis
1 (.57%)
Skin Oedema
1 (.57%)
Spinal Osteoarthritis
1 (.57%)
Systemic Inflammatory Response Synd...
1 (.57%)
Tension
1 (.57%)
Treatment Noncompliance
1 (.57%)
Varicella
1 (.57%)
Vertigo
1 (.57%)
Vestibular Neuronitis
1 (.57%)
Viral Infection
1 (.57%)
Walking Disability
1 (.57%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Betaserc, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Betaserc is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Betaserc

What are the most common Betaserc adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Betaserc, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Betaserc is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Betaserc According to Those Reporting Adverse Events

Why are people taking Betaserc, according to those reporting adverse events to the FDA?

Vertigo
26
Menieres Disease
16
Dizziness
15
Labyrinthitis
12
Drug Use For Unknown Indication
12
Product Used For Unknown Indication
8
Show More Show More
Multiple Sclerosis
6
Deafness
3
Tinnitus
3
Balance Disorder
3
Viiith Nerve Lesion
2
Dementia Alzheimers Type
1
Otitis Media
1
Influenza
1
Unevaluable Event
1
Vestibular Neuronitis
1
Ear Disorder
1

Betaserc Case Reports

What Betaserc safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Betaserc. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Betaserc.